Clinical trial
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic…
NCT00163657 · Baylor Research Institute, Other · Completed
Key facts
| NCT number | NCT00163657 |
|---|---|
| Title | Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection |
| Official title | An Open-Label, Randomized, Prospective Multicenter Study To Compare The Efficacy And Safety Among 3 Immunosuppressant Treatment Regimens In Patients Receiving A Liver Transplant For ESLD Caused By Chronic Hepatitis C |
| Lead sponsor | Baylor Research Institute, Other |
| Collaborators | Baylor Health Care System Emory University University of Southern California Mayo Clinic - Scottsdale/Phoenix, Arizona New York Presbyterian Hospital Oregon Health and Science University New York… |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | End Stage Liver Disease, Hepatitis C |
| Intervention type | Drug |
| Interventions | Daclizumub, Tacrolimus, Cyclosporine, MMF |
| Enrollment | 312 |
| Start date | Jul 1, 2002 |
| Primary completion | Apr 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: